- A Network Pharmacology Study to Uncover the Mechanism of FDY003 for Ovarian Cancer Treatment
Ho-Sung Lee et al, 2022, Natural Product Communications CrossRef - Methiothepin Suppresses Human Ovarian Cancer Cell Growth by Repressing Mitochondrion-Mediated Metabolism and Inhibiting Angiogenesis In Vivo
Jin-Young Lee et al, 2020, Pharmaceutics CrossRef - How does estrogen work on autophagy?
Jin Xiang et al, 2019, Autophagy CrossRef - Mechanisms of Taxane Resistance
Sara M. Maloney et al, 2020, Cancers CrossRef - Autophagy as an emerging therapy target for ovarian carcinoma
Lei Zhan et al, 2016, Oncotarget CrossRef - Efficacy evaluation of multi-immunotherapy in ovarian cancer: From bench to bed
Xiaoyi Hu et al, 2022, Frontiers in Immunology CrossRef - Combined treatment of All-trans retinoic acid with Tamoxifen suppresses ovarian cancer
Rui Xu et al, 2024, Cancer Chemotherapy and Pharmacology CrossRef - Treating gynecologic malignancies with selective estrogen receptor downregulators (SERDs): promise and challenges
Michelle M. Boisen et al, 2015, Molecular and Cellular Endocrinology CrossRef - Role of c-Src in Carcinogenesis and Drug Resistance
Lukmon Raji et al, 2023, Cancers CrossRef